SecSonar.com

Voyager Therapeutics, Inc. (VYGR)

Voyager Therapeutics, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Voyager Therapeutics, Inc. (VYGR) is a Biotechnology company based in US with a market capitalization of $235.3M. Revenue declined 49.5% year-over-year and free cash flow was negative at -$135.1M. This page tracks VYGR's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 172 employees · IPO Nov 11, 2015

Valuation

Valuation & price

$3.77 · as of May 17, 2026 · -29.4% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

1.20

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$5.33$4.19$3.04Jul 25Dec 25Jul 26Jul 7, 25$3.04Jul 9, 25$3.47Jul 11, 25$3.49Jul 15, 25$3.08Jul 17, 25$3.22Jul 21, 25$3.17Jul 23, 25$3.28Jul 25, 25$3.24Jul 29, 25$3.20Jul 31, 25$3.19Aug 4, 25$3.21Aug 6, 25$3.40Aug 11, 25$3.08Aug 13, 25$3.65Aug 15, 25$3.73Aug 19, 25$3.56Aug 21, 25$3.36Aug 25, 25$3.34Aug 27, 25$3.42Aug 29, 25$3.36Sep 3, 25$3.68Sep 5, 25$4.24Sep 9, 25$4.01Sep 11, 25$4.38Sep 16, 25$4.25Sep 18, 25$4.49Sep 22, 25$4.22Sep 24, 25$4.25Sep 26, 25$4.52Sep 30, 25$4.67Oct 2, 25$4.72Oct 6, 25$4.95Oct 8, 25$5.28Oct 10, 25$5.00Oct 14, 25$4.98Oct 16, 25$5.33Oct 21, 25$4.97Oct 23, 25$4.55Oct 27, 25$4.81Oct 29, 25$4.61Oct 31, 25$4.67Nov 4, 25$4.16Nov 6, 25$4.22Nov 10, 25$4.26Nov 12, 25$4.25Nov 14, 25$3.93Nov 18, 25$4.28Nov 20, 25$4.09Nov 25, 25$3.97Nov 28, 25$4.09Dec 2, 25$3.77Dec 4, 25$4.35Dec 8, 25$4.32Dec 10, 25$4.42Dec 12, 25$4.39Dec 16, 25$4.42Dec 18, 25$4.12Dec 22, 25$4.21Dec 24, 25$4.07Dec 29, 25$4.04Jan 2, 26$4.03Jan 6, 26$4.02Jan 8, 26$4.06Jan 12, 26$3.90Jan 14, 26$4.13Jan 16, 26$3.76Jan 21, 26$3.77Jan 23, 26$4.00Jan 27, 26$3.94Jan 29, 26$3.98Feb 2, 26$4.00Feb 4, 26$3.74Feb 9, 26$3.71Feb 11, 26$3.65Feb 13, 26$3.39Feb 18, 26$3.34Feb 20, 26$3.49Feb 24, 26$3.78Feb 26, 26$4.23Mar 2, 26$4.15Mar 4, 26$4.13Mar 6, 26$3.90Mar 10, 26$5.00Mar 12, 26$4.87Mar 17, 26$3.92Mar 19, 26$3.74Mar 23, 26$3.88Mar 25, 26$4.03Mar 27, 26$3.96Mar 31, 26$3.86Apr 2, 26$3.96Apr 7, 26$3.96Apr 9, 26$3.96Apr 13, 26$3.84Apr 15, 26$4.03Apr 17, 26$4.13Apr 22, 26$4.14Apr 24, 26$3.79Apr 28, 26$3.77Apr 30, 26$3.73May 4, 26$3.88May 6, 26$4.17May 8, 26$4.05May 12, 26$4.15May 14, 26$4.24May 18, 26$3.53May 20, 26$3.50May 22, 26$3.80May 28, 26$3.90Jun 1, 26$3.79Jun 3, 26$3.60Jun 5, 26$3.33Jun 9, 26$3.43Jun 11, 26$3.46Jun 15, 26$3.63Jun 17, 26$3.62Jun 22, 26$3.72Jun 24, 26$3.68Jun 26, 26$3.59Jul 2, 26$3.78
$2.9652-week range$5.33
Loading valuation history…

Fundamentals

Key fundamentals

$235.3M

Market cap

-49.5%

Revenue growth (YoY)

100.0%

Gross margin

-$135.1M

Free cash flow (USD)

-$159.9M

Net debt

Net cash position

1.8%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$14.2MFY 2017$10.1MFY 2018$7.6MFY 2019$104.4MFY 2020$171.1MFY 2021$37.4MFY 2022$40.9MFY 2023$250.0MFY 2024$80.0MFY 2025$40.4M
$14.2M$40.4M

Free cash flow by year

2016 → 2025

FY 2016$-47.5MFY 2017$-65.3MFY 2018$-20.2MFY 2019$40.9MFY 2020$-108.8MFY 2021$-55.1MFY 2022$-15.0MFY 2023$74.7MFY 2024$-18.8MFY 2025$-135.1M
-$47.5M-$135.1M

Gross margin by year

2021 → 2025

FY 2021-97.2%FY 2022-36.3%FY 202363.1%FY 2024100.0%FY 2025100.0%
-97.2%100.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAuthorized Shares IncreaseJun 10, 2026Filing
  • 8-K eventFDA ClearanceJun 1, 2026Filing
  • Quarterly report10-Q FiledMay 7, 2026Filing
  • 8-K eventEarnings ReleaseMay 7, 2026Filing
  • 8-K eventCFO Resignation and AppointmentsApr 21, 2026Filing
  • Insider sellInsider Sell $45KSandrock Alfred · Director, President and CEO · $44.5KApr 3, 2026Filing

Questions

Frequently asked questions

What is Voyager Therapeutics, Inc.'s market cap?

Voyager Therapeutics, Inc. (VYGR) has a market capitalization of $235.3M.

What is VYGR's P/E ratio?

A meaningful P/E ratio is not available for VYGR — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is VYGR's price-to-book (P/B) ratio?

VYGR trades at 1.20 times book value per share.

Are insiders buying VYGR stock?

SEC Form 4 filings show no open-market insider buys at Voyager Therapeutics, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

QSI

Quantum-Si incorporated

$235.4M

CRBU

Caribou Biosciences, Inc.

$235.6M

SGMT

Sagimet Biosciences Inc.

$235M

OBIO

Orchestra BioMed Holdings, Inc.

$236.8M

WHWK

Whitehawk Therapeutics Inc

$232.4M

ALEC

Alector, Inc.

$242.6M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.